Form 8-K - Current report:
SEC Accession No. 0001213900-25-011774
Filing Date
2025-02-10
Accepted
2025-02-10 16:40:45
Documents
14
Period of Report
2025-02-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0230532-8k_rafael.htm   iXBRL 8-K 31240
2 AMENDMENT NO. 2 TO AGREEMENT AND PLAN OF MERGER DATED AS OF FEBRUARY 4, 2025 BY ea0230532ex2-1_rafael.htm EX-2.1 24951
  Complete submission text file 0001213900-25-011774.txt   232144

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE rfl-20250204.xsd EX-101.SCH 3030
4 XBRL LABEL FILE rfl-20250204_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE rfl-20250204_pre.xml EX-101.PRE 22370
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0230532-8k_rafael_htm.xml XML 3556
Mailing Address 520 BROAD STREET NEWARK NJ 07120
Business Address 520 BROAD STREET NEWARK NJ 07120 212-658-1450
Rafael Holdings, Inc. (Filer) CIK: 0001713863 (see all company filings)

EIN.: 822296593 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-38411 | Film No.: 25606261
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)